A generic ⁸⁹Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography

Nan Li1 Division of Imaging Sciences and Biomedical Engineering, St Thomas’ Hospital, King’s College London, London, UK;2 Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People’s Republic of China

Zilin Yu1 Division of Imaging Sciences and Biomedical Engineering, St Thomas’ Hospital, King’s College London, London, UK

Truc Thuy Pham1 Division of Imaging Sciences and Biomedical Engineering, St Thomas’ Hospital, King’s College London, London, UK

Philip J Blower1 Division of Imaging Sciences and Biomedical Engineering, St Thomas’ Hospital, King’s College London, London, UK

Ran Yan1 Division of Imaging Sciences and Biomedical Engineering, St Thomas’ Hospital, King’s College London, London, UKCorrespondence[email protected]

Pages 3281-3294 | Published online: 20 Apr 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

FenskeDBChonnACullisPRLiposomal nanomedicines: an emerging fieldToxicol Pathol2008361212918337218
PubMed Web of Science ®Google Scholar
TaTPorterTMThermosensitive liposomes for localized delivery and triggered release of chemotherapyJ Control Release20131691–211212523583706
PubMed Web of Science ®Google Scholar
NobleGTStefanickJFAshleyJDKiziltepeTBilgicerBLigand-targeted liposome design: challenges and fundamental considerationsTrends Biotechnol2014321324524210498
PubMed Web of Science ®Google Scholar
McGranahanNSwantonCBiological and therapeutic impact of intratumor heterogeneity in cancer evolutionCancer Cell2015271152625584892
PubMed Web of Science ®Google Scholar
GambhirSSMolecular imaging of cancer with positron emission tomographyNat Rev Cancer20022968369312209157
PubMed Web of Science ®Google Scholar
EmmetiereFIrwinCViola-VillegasNT18F-labeled-bioorthogonal liposomes for in vivo targetingBioconjug Chem201324111784178924180480
PubMedGoogle Scholar
PetersenALBinderupTRasmussenP64Cu loaded liposomes as positron emission tomography imaging agentsBiomaterials20113292334234121216003
PubMed Web of Science ®Google Scholar
AbouDSThorekDLRamosNN89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancerPharm Res201330387888823224977
PubMed Web of Science ®Google Scholar
SeoJWMahakianLMTamSThe pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor modelNucl Med Biol201542215516325451215
PubMed Web of Science ®Google Scholar
Pérez-MedinaCAbdel-AttiDZhangYA modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targetingJ Nucl Med201455101706171125060196
PubMedGoogle Scholar
FerrisTJCharoenphunPMeszarosLKMullenGEDBlowerPJWentMJSynthesis and characterisation of zirconium complexes for cell tracking with Zr-89 by positron emission tomographyDalton Trans20144339148511485725164373
PubMedGoogle Scholar
CharoenphunPMeszarosLKChuamsaamarkkeeK[89Zr] Oxinate4 for long-term in vivo cell tracking by positron emission tomographyEur J Nucl Med Mol Imaging201542227828725359636
PubMedGoogle Scholar
EdmondsSVolpeAShmeedaHExploiting the metal-chelating properties of the drug cargo for in vivo positron emission tomography imaging of liposomal nanomedicinesACS Nano20161011102941030727781436
PubMedGoogle Scholar
TanXPangXLeiMAn efficient dual-loaded multifunctional nanocarrier for combined photothermal and photodynamic therapy based on copper sulfide and chlorin e6Int J Pharm20165031–222022826988376
PubMedGoogle Scholar
GuoFYuMWangJTanFLiNSmart IR780 theranostic nanocarrier for tumor-specific therapy: hyperthermia-mediated bubble-generating and folate-targeted liposomesACS Appl Mater Interfaces2015737205562056726322900
PubMed Web of Science ®Google Scholar
MarikJTartisMSZhangHLong-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP)Nucl Med Biol200734216517117307124
PubMed Web of Science ®Google Scholar
DrummondDCNobleCOHayesMEParkJWKirpotinDBPharmacokinetics and in vivo drug release rates in liposomal nanocarrier developmentJ Pharm Sci200897114696474018351638
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A generic ⁸⁹Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

A generic ⁸⁹Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography